Dec 31, 2013

Xenon Pharmaceuticals Q4 2013 Earnings Report

Total Revenue
$5.58M
Previous year: $14.3M
-61.0%
EPS
$2.67
Previous year: -$0.667
-499.9%
Gross Profit
$3.78M
Previous year: $977K
+286.6%
Cash and Equivalents
$38M
Previous year: $60.2M
-36.9%
Total Assets
$54.5M

Xenon Pharmaceuticals

Xenon Pharmaceuticals